English
简体中文
Total: £ 56.28
2025-11-12 | Pages: 165 | Tables: 165
The global Targeted Protein Degrader Technology market is projected to grow from US$ 102 million in 2024 to US$ 363 million by 2031, at a CAGR of 18.3% (2025-2031), driven by critical product segments and diverse end‑use applications.Targeted protein...
2025-11-12 | Pages: 146 | Tables: 154
The global Skin Substitutes from Biological Sources market is projected to grow from US$ 1900 million in 2024 to US$ 4107 million by 2031, at a CAGR of 11.8% (2025-2031), driven by critical product segments and diverse end‑use applications.Biological...
2025-11-12 | Pages: 142 | Tables: 142
The global Modular Healthcare Buildings market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.Modular Healthcare Buildings refer to...
2025-11-12 | Pages: 120 | Tables: 123
The global Small Molecule Drug 3D Printing market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.Small Molecule Drug 3D Printing re...
2025-11-12 | Pages: 160 | Tables: 147
The global Rehabilitation Evaluation Equipment market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.Rehabilitation Evaluation Equi...
2025-11-12 | Pages: 133 | Tables: 140
The global Cold Pain Therapy OTC Products market is projected to grow from US$ 1388 million in 2024 to US$ 1944 million by 2031, at a CAGR of 5.0% (2025-2031), driven by critical product segments and diverse end‑use applications.Cryotherapy means col...
2025-11-12 | Pages: 125 | Tables: 118
The global Life Sciences IT market is projected to grow from US$ 23800 million in 2024 to US$ 48920 million by 2031, at a CAGR of 11.0% (2025-2031), driven by critical product segments and diverse end‑use applications.Life science IT plays a crucial ...
2025-11-12 | Pages: 125 | Tables: 117
The global Biomarker of Disease market is projected to grow from US$ 32340 million in 2024 to US$ 89610 million by 2031, at a CAGR of 15.9% (2025-2031), driven by critical product segments and diverse end‑use applications.Omics, proteomics, meta-bolo...
2025-11-12 | Pages: 145 | Tables: 144
The global Acute Ocular Pain market is projected to grow from US$ 440 million in 2024 to US$ 798 million by 2031, at a CAGR of 9.0% (2025-2031), driven by critical product segments and diverse end‑use applications.Acute ocular pain, commonly referred...
2025-11-12 | Pages: 122 | Tables: 126
The global Goat Polyclonal Antibody market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.Goat polyclonal antibody is an antibody p...
2025-11-12 | Pages: 110 | Tables: 114
The global market for Pharmaceutical Environmental Monitoring was estimated to be worth US$ 976 million in 2024 and is forecast to a readjusted size of US$ 1517 million by 2031 with a CAGR of 6.6% during the forecast period 2025-2031.The Pharmaceutic...
2025-11-12 | Pages: 131 | Tables: 126
The global market for miRNA Tools and Services was estimated to be worth US$ 680 million in 2024 and is forecast to a readjusted size of US$ 1640 million by 2031 with a CAGR of 13.6% during the forecast period 2025-2031.microRNA (abbreviated miRNA) i...
2025-11-12 | Pages: 105 | Tables: 106
The global market for Pathological Examination was estimated to be worth US$ 34130 million in 2024 and is forecast to a readjusted size of US$ 65910 million by 2031 with a CAGR of 10.0% during the forecast period 2025-2031.A pathomorphological method...
2025-11-12 | Pages: 82 | Tables: 99
The global market for Organoids was estimated to be worth US$ 67 million in 2024 and is forecast to a readjusted size of US$ 215 million by 2031 with a CAGR of 18.4% during the forecast period 2025-2031.Organoids are in-vitro derived 3D cell aggregat...
2025-11-12 | Pages: 71 | Tables: 74
The global market for Dialysis Induced Anemia Treatment was valued at US$ 1947 million in the year 2024 and is projected to reach a revised size of US$ 2932 million by 2031, growing at a CAGR of 5.8% during the forecast period.Dialysis Induced Anemia...
